(Q40144380)

English

Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro

scientific article published on 18 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

5

object named as

Peter Nygren

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

6

object named as

Rolf Larsson

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Linda Rickardson

2

object named as

Linda Rickardson

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

7

object named as

Anna Aleskog

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Elin Lindhagen

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Gary Elliott

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Lorenzo Leoni

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

18 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

297-303

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10637-007-9049-4

21 January 2018

Apoptosis induced by molecular targeting therapy in hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the Wnt signaling pathway in chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-007-9049-4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40144380&oldid=2203441757"